NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.475
+0.020 (0.81%)
Aug 7, 2025, 12:56 PM - Market open

Accolade Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
4827387528166
Upgrade
Market Cap Growth
-22.68%-30.71%-48.99%-73.29%328.57%1.96%
Upgrade
Enterprise Value
51313957243-
Upgrade
Last Close Price
2.462.204.6011.1047.80244.00
Upgrade
PB Ratio
--1.14-3.2610.1313.51-1.50
Upgrade
P/TBV Ratio
---10.1313.51-
Upgrade
Debt / Equity Ratio
-0.33-0.27-0.781.420.03-0.02
Upgrade
Quick Ratio
0.170.070.241.292.320.06
Upgrade
Current Ratio
0.220.150.361.662.740.06
Upgrade
Return on Equity (ROE)
----281.79%--
Upgrade
Return on Assets (ROA)
-191.74%-224.60%-104.08%-94.66%-330.91%-378.83%
Upgrade
Return on Capital (ROIC)
---224.47%-141.17%--
Upgrade
Earnings Yield
-50.35%-94.69%-78.73%-52.95%-33.11%-78.94%
Upgrade
FCF Yield
-21.82%-40.09%-56.56%-52.96%-13.41%-3.46%
Upgrade
Buyback Yield / Dilution
-54.22%-40.50%-15.20%-40.17%-36.90%-220.58%
Upgrade
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q